Lipella Pharmaceuticals Statistics
Total Valuation
LIPO has a market cap or net worth of $3.48 million. The enterprise value is $1.49 million.
| Market Cap | 3.48M |
| Enterprise Value | 1.49M |
Important Dates
The next estimated earnings date is Monday, August 12, 2024, before market open.
| Earnings Date | Aug 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
LIPO has 7.61 million shares outstanding. The number of shares has increased by 26.96% in one year.
| Shares Outstanding | 7.61M |
| Shares Change (YoY) | +26.96% |
| Shares Change (QoQ) | +7.71% |
| Owned by Insiders (%) | 36.79% |
| Owned by Institutions (%) | 4.99% |
| Float | 4.80M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 7.30 |
| Forward PS | n/a |
| PB Ratio | 1.36 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.13 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.46, with a Debt / Equity ratio of 0.05.
| Current Ratio | 5.46 |
| Quick Ratio | 3.94 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -868.63 |
Financial Efficiency
Return on equity (ROE) is -171.60% and return on invested capital (ROIC) is -182.26%.
| Return on Equity (ROE) | -171.60% |
| Return on Assets (ROA) | -145.40% |
| Return on Capital (ROIC) | -182.26% |
| Revenue Per Employee | $95,490 |
| Profits Per Employee | -$948,590 |
| Employee Count | 5 |
| Asset Turnover | 0.15 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -78.89% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -78.89% |
| 50-Day Moving Average | 0.66 |
| 200-Day Moving Average | 0.97 |
| Relative Strength Index (RSI) | 28.07 |
| Average Volume (20 Days) | 47,435 |
Short Selling Information
The latest short interest is 23,115, so 0.30% of the outstanding shares have been sold short.
| Short Interest | 23,115 |
| Short Previous Month | 22,254 |
| Short % of Shares Out | 0.30% |
| Short % of Float | 0.48% |
| Short Ratio (days to cover) | 0.82 |
Income Statement
In the last 12 months, LIPO had revenue of $477,449 and -$4.74 million in losses. Loss per share was -$0.75.
| Revenue | 477,449 |
| Gross Profit | 477,449 |
| Operating Income | -4.88M |
| Pretax Income | -4.74M |
| Net Income | -4.74M |
| EBITDA | -4.74M |
| EBIT | -4.74M |
| Loss Per Share | -$0.75 |
Balance Sheet
The company has $2.11 million in cash and $115,702 in debt, giving a net cash position of $1.99 million or $0.26 per share.
| Cash & Cash Equivalents | 2.11M |
| Total Debt | 115,702 |
| Net Cash | 1.99M |
| Net Cash Per Share | $0.26 |
| Equity (Book Value) | 2.56M |
| Book Value Per Share | 0.34 |
| Working Capital | 2.46M |
Cash Flow
In the last 12 months, operating cash flow was -$3.46 million and capital expenditures -$14,434, giving a free cash flow of -$3.48 million.
| Operating Cash Flow | -3.46M |
| Capital Expenditures | -14,434 |
| Free Cash Flow | -3.48M |
| FCF Per Share | -$0.48 |
Margins
Gross margin is 100.00%, with operating and profit margins of -1,021.92% and -993.39%.
| Gross Margin | 100.00% |
| Operating Margin | -1,021.92% |
| Pretax Margin | -993.39% |
| Profit Margin | -993.39% |
| EBITDA Margin | -991.88% |
| EBIT Margin | -992.25% |
| FCF Margin | -727.84% |
Dividends & Yields
LIPO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -26.96% |
| Shareholder Yield | -26.96% |
| Earnings Yield | -136.16% |
| FCF Yield | -99.76% |
Analyst Forecast
The average price target for LIPO is $2.00, which is 354.44% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $2.00 |
| Price Target Difference | 354.44% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
LIPO has an Altman Z-Score of -5.4 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -5.4 |
| Piotroski F-Score | 3 |